224 220
225 221
226 222
227 223
228 224
229 225
230 227
231 228
232 229
233 230
234 231
235 232
236 233
237 234
238 235
239 236
240 237
241 238
242 239
243 240
244 241
245 242
246 243
247 244
248 245
249 246
250 247
251 248
252 249
253 250
254 251
255 252
256 253
257 254
258 255
259 256
260 257
261 258
262 259
263 260
264 261
265 262
266 263
267 264
268 265
269 267
270 268
271 269
272 270
273 271
274 272
275 273
276 274
277 275
278 276
279 277
280 278
281 279
282 280
283 281
284 282
285 283
286 284
287 285
288 286
289 287
290 288
291 289
292 290
293 291
294 292
295 293
296 294
297 295
298 296
299 297
300 298
301 299
302 300
303 301
304 302
305 303
306 304
307 305
308 306
309 307
310 308
311 309
312 310
313 311
314 312
315 313
316 314
317 315
318 316
319 317
320 318
321 319
322 320
323 321
324 322
325 323
326 324
327 325
Scrivener Publishing
100 Cummings Center, Suite 541J
Beverly, MA 01915-6106
Publishers at Scrivener
Martin Scrivener ([email protected])
Phillip Carmical ([email protected])
Nanovaccinology as Targeted Therapeutics
Edited by
Kaushik Pal
University Centre for Research and Development (UCRD), Department of Physics, Chandigarh University, Mohali, Punjab, India
This edition first published 2022 by John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA and Scrivener Publishing LLC, 100 Cummings Center, Suite 541J, Beverly, MA 01915, USA
© 2022 Scrivener Publishing LLC
For more information about Scrivener publications please visit www.scrivenerpublishing.com.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying,